Merck healthcare managing director Josie Downey said, “The new listing provides continuity of access to patients who may have started the treatment in childhood, and more options for the Australian patient community, in particular for adult patients who may have injured their pituitary and need lifelong replacement.”
Merck welcomes new PBS listing for adults with severe growth hormone deficiency
November 1, 2023 Latest NewsBioPharma
Latest Video
New Stories
-
Medicines Australia seeks answers on AI in HTA process
September 23, 2026 - - Latest News -
The prevention gap and inside Sally Panton's bet on cellular health
September 23, 2026 - - Latest News -
Pfizer 'deeply disappointed' in response to PBAC refusing to move on price
September 23, 2026 - - Latest News -
Lilly goes direct with a patient platform for its non-PBS medicines
September 23, 2026 - - Latest News -
A 'multistakeholder' reference group to shadow agreement negotiations
September 23, 2026 - -
If there is a productivity gain in the process, then it should be passed on
September 22, 2026 - - Latest News -
Given the official use of AI, a cease and desist would not be unreasonable
September 22, 2026 - - Latest News
